Author(s):
Prakash Nathaniel Kumar Sarella, Srujala Vegi, Veera Kumari Vendi, Anil Kumar Vipparthi, Surekha Valluri
Email(s):
sarellaprakash@acop.edu.in
DOI:
10.52711/2231-5691.2024.00026 
Address:
Prakash Nathaniel Kumar Sarella*, Srujala Vegi, Veera Kumari Vendi, Anil Kumar Vipparthi, Surekha Valluri
Department of Pharmaceutics, Aditya College of Pharmacy, ADB Road, Surampalem, Kakinada 533437, Andhra Pradesh, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 2,
Year - 2024
ABSTRACT:
Nanotechnology has revolutionized the field of drug delivery, providing novel strategies to enhance drug efficacy and reduce side effects. Among these advancements, Aquasomes have emerged as promising nanocarriers, representing a unique class of colloidal delivery systems. Aquasomes are three-dimensional, self-assembling nanocomposites composed of a solid core coated with a layer of biocompatible polymers and stabilized by surfactants. Notably, the hydrophilic nature of Aquasomes allows them to encapsulate hydrophobic drugs, thereby overcoming solubility and stability challenges commonly associated with conventional drug formulations. The versatility of Aquasomes in encapsulating a wide range of drug molecules, including small molecules, proteins, and nucleic acids, expands their potential in various therapeutic areas. The applications of aquasomes are examined in targeted drug delivery, enabling site-specific release and minimizing off-target effects in this review. Moreover, the advantages of Aquasomes in improving drug stability and bioavailability are analyzed, and comparative assessments with other nanocarriers are presented. The potential challenges and ongoing research efforts to optimize Aquasome formulations for clinical translation are also discussed. Aquasomes offer a promising outlook for nanotechnology-based drug delivery, showing great potential in addressing existing limitations of conventional drug formulations. The constant progress in Aquasome research fuels optimism for their integration into mainstream therapeutics, revolutionizing medical treatments and patient outcomes.
Cite this article:
Prakash Nathaniel Kumar Sarella, Srujala Vegi, Veera Kumari Vendi, Anil Kumar Vipparthi, Surekha Valluri. Exploring Aquasomes: A Promising Frontier in Nanotechnology-based Drug Delivery. Asian Journal of Pharmaceutical Research. 2024; 14(2):153-1. doi: 10.52711/2231-5691.2024.00026
Cite(Electronic):
Prakash Nathaniel Kumar Sarella, Srujala Vegi, Veera Kumari Vendi, Anil Kumar Vipparthi, Surekha Valluri. Exploring Aquasomes: A Promising Frontier in Nanotechnology-based Drug Delivery. Asian Journal of Pharmaceutical Research. 2024; 14(2):153-1. doi: 10.52711/2231-5691.2024.00026 Available on: https://www.asianjpr.com/AbstractView.aspx?PID=2024-14-2-11
REFERENCES:
1. De Villiers MM, Aramwit P, Kwon GS. Nanotechnology in Drug Delivery. Springer Science and Business Media; 2008.
2. Emilian Leucuta S. Nanotechnology for delivery of drugs and biomedical applications. Current Clinical Pharmacology 2010; 5(4): 257-80. doi: 10.2174/157488410793352003
3. Rai M, dos Santos CA. Nanotechnology Applied to Pharmaceutical Technology. Springer; 2017.
4. Manikiran SS, Krishna CS, Rao R. Aquasomes: role to deliver bioactive substances. Research Journal of Pharmaceutical Dosage Forms and Technology. 2010; 2(6): 356-60.
5. Yadav AR, Mohite SK. Aquasomes as a self assembling nanobiopharmaceutical carrier system for bio-active molecules. Research Journal of Topical and Cosmetic Sciences. 2020; 11(2): 89-94. doi: 10.5958/2321-5844.2020.00016.3
6. Chaudhary JS. Aquasomes; A new approach for delivering therapeutics: an overview. Asian Journal of Pharmaceutics (AJP). 2018; 12(02).
7. Kulkarni S, Prabhakar B, Shende P. Aquasomes: Advanced Vesicular-based Nanocarrier Systems. Current Pharmaceutical Design. 2022; 28(29): 2404-14. doi: 10.2174/1381612828666220728112741
8. Rojas-Oviedo I, Salazar-Lopez RA, Reyes-Gasga J, Quirino-Barreda CT. Elaboration and structural analysis of aquasomes loaded with indomethacin. European Journal of Pharmaceutical Sciences. 2007; 32(3): 223-30. doi: 10.1016/j.ejps.2007.07.008
9. Banerjee S, Sen KK. Aquasomes: A novel nanoparticulate drug carrier. Journal of Drug Delivery Science and Technology. 2018; 43: 446-52. doi: 10.1016/j.jddst.2017.11.011
10. Goyal AK, Khatri K, Mishra N, Mehta A, Vaidya B, Tiwari S, et al. Aquasomes—a nanoparticulate approach for the delivery of antigen. Drug Development and Industrial Pharmacy. 2008; 34(12): 1297-305. doi: 10.1080/03639040802071661
11. Sutariya V, Patel P. Aquasomes: A novel carrier for drug delivery. International Journal of Pharmaceutical Sciences and Research 2012;3(3):688.
12. Umashankar MS, Sachdeva RK, Gulati M. Aquasomes: a promising carrier for peptides and protein delivery. Nanomedicine: Nanotechnology, Biology and Medicine. 2010; 6(3): 419-26. doi: 10.1016/j.nano.2009.11.002
13. Jain SS, Jagtap PS, Dand NM, Jadhav KR, Kadam VJ. Aquasomes: A novel drug carrier. Journal of Applied Pharmaceutical Science. 2012:184-92.
14. Shahabade Gururaj S, Bhosale Ashok V, Mutha Swati S, Bhosale Nilesh R, Khade Prashant H, Bhadane Nishant P, et al. An overview on nanocarrier technology-Aquasomes. Journal of Pharmacy Research. 2009; 2(7): 1174-7.
15. Swapnil K, Vijay S, Chandrakant M. Targeted Drug Delivery: A Backbone for Cancer Therapy. Asian Journal of Pharmaceutical Research. 2013; 3(1): 40-6.
16. Rama A, Pai A, Barreto DR, Kannan SK, Naha A. Virus-Like particles as a Novel Targeted Drug Delivery Platform for Biomedical Applications. Research Journal of Pharmacy and Technology. 2022; 15(6): 2801-8. doi: 10.52711/0974-360X.2022.00468
17. Asfour MH. Advanced trends in protein and peptide drug delivery: a special emphasis on aquasomes and microneedles techniques. Drug Delivery and Translational Research. 2021; 11: 1-23. doi: 10.1007/s13346-020-00746-z
18. Agrahari V, Agrahari V, Mitra AK. Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities. Ther Deliv. 2016; 7(4): 257-78. doi: 10.4155/tde-2015-0012
19. Ahuja G, Pathak K. Porous Carriers for Controlled/Modulated Drug Delivery. Indian J Pharm Sci. 2009; 71(6): 599-607. doi: 10.4103/0250-474X.59540
20. Bera S, Mondal D. A role for ultrasound in the fabrication of carbohydrate-supported nanomaterials. J Ultrasound. 2019; 22(2): 131-56. doi: 10.1007/s40477-019-00363-8
21. Banker GS. The theory and practice of industrial pharmacy. Vol. 1. Edited by Leon Lachman, Herbert A. Lieberman, and Joseph L. Kanig. Lea & Febiger, Philadelphia, PA 19106, 1970. xii+ 811 pp. 15.5$\times$ 23 cm. Price $24.50. Published online 1970.
22. Chauhan R, El-Baz N, Keynton RS, James KT, Malik DA, Zhu M, et al. Targeted Gold Nanoparticle–Oligonucleotide Contrast Agents in Combination with a New Local Voxel-Wise MRI Analysis Algorithm for In Vitro Imaging of Triple-Negative Breast Cancer. Nanomaterials (Basel). 2019; 9(5): 709. doi: 10.3390/nano9050709
23. Douloudi M, Nikoli E, Katsika T, Vardavoulias M, Arkas M. Dendritic Polymers as Promising Additives for the Manufacturing of Hybrid Organoceramic Nanocomposites with Ameliorated Properties Suitable for an Extensive Diversity of Applications. Nanomaterials (Basel). 2020; 11(1): 19. doi: 10.3390/nano11010019
24. Gomes A, Aguiar L, Ferraz R, Teixeira C, Gomes P. The Emerging Role of Ionic Liquid-Based Approaches for Enhanced Skin Permeation of Bioactive Molecules: A Snapshot of the Past Couple of Years. Int J Mol Sci. 2021; 22(21): 11991. doi: 10.3390/ijms222111991
25. Kumar D, Sharma D, Singh G, Singh M, Rathore MS. Lipoidal Soft Hybrid Biocarriers of Supramolecular Construction for Drug Delivery. ISRN Pharm. 2012; 2012: 474830. doi: 10.5402/2012/474830
26. Ahmad W, Khan T, Basit I, Imran J. A Comprehensive Review on Targeted Drug Delivery System. AJPR Published online. November 22, 2022:335-40. doi: 10.52711/2231-5691.2022.00053
27. Selvaraju K, Prabhu KV, Karthick K, Preetha JP, Kumaran KSG. Pharmacosomes-An Immense Potential Vesicular Constructs. Research Journal of Pharmaceutical Dosage Forms and Technology. 2011; 3(3): 84-6.
28. Kalra N, Nyola N, Sharma R, Singh G, Choudhary S. A review on unique Targeted drug carrier system. Research Journal of Pharmacy and Technology. 2011; 4(6): 835-41.
29. Liu H, Zhu J, Bao P, Ding Y, Shen Y, Webster TJ, et al. Construction and in vivo/in vitro evaluation of a nanoporous ion-responsive targeted drug delivery system for recombinant human interferon α-2b delivery. Int J Nanomedicine. 2019; 14: 5339-53. doi: 10.2147/IJN.S209646
30. Mehanna MM, Mneimneh AT. Formulation and Applications of Lipid-Based Nanovehicles: Spotlight on Self-emulsifying Systems. Adv Pharm Bull. 2021; 11(1): 56-67. doi: 10.34172/apb.2021.006
31. Jeganath S, Abdelmagid KFK. A review on nanosponges-A promising novel drug delivery system. Research Journal of Pharmacy and Technology. 2021; 14(1): 501-5. doi: 10.5958/0974-360X.2021.00091.3
32. Stefanov SR, Andonova VY. Lipid Nanoparticulate Drug Delivery Systems: Recent Advances in the Treatment of Skin Disorders. Pharmaceuticals (Basel). 2021; 14(11): 1083. doi: 10.3390/ph14111083
33. Upadhyay RK. Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier. Biomed Res Int. 2014; 2014: 869269. doi: 10.1155/2014/869269
34. Bornare AS, Saudagar RB. Nanostructured lipid carrier (NLC): a modern approach for transdermal drug delivery. Research Journal of Pharmacy and Technology. 2017; 10(8): 2784-92.
35. Gupta R, Singhal M. Transferosomes as an efficient carrier system for better therapeutic response of targeted drug delivery system. Research Journal of Pharmacy and Technology. 2022; 15(2): 913-20. doi: 10.52711/0974-360X.2022.00153
36. Devi GC, Kumar AE. Microbubbles-A Potential Novel Targeted Drug Delivery. Research Journal of Pharmacy and Technology. 2019; 12(5): 2511-6. doi: 10.5958/0974-360X.2019.00423.2
37. Saravanan V, Tippavajhala VK. Quantum Dots: Targeted and Traceable Drug Delivery System. Research Journal of Pharmacy and Technology. 2022; 15(12): 5895-902. doi: 10.52711/0974-360X.2022.00994